Ligand profile

ZINC9051070

Virtual-screening candidate from ZINC.

Bound to: KP13_03591 — UDP-2,3-diacylglucosamine hydrolase

Via homolog UniProtA6T5R0 FormulaC₂₂H₂₃F₃N₂O₃S
Tanimoto 0.58
Mol. weight 452.50 Da
Permeability High
PAINS Clean

Identifiers

Database identifiers and provenance.

Ligand ID
ZINC9051070
UniProt (similar protein)
A6T5R0
Tanimoto
0.578
Target protein
KP13_03591

Structure

2D representation rendered from SMILES.

Physicochemical properties

Computed with RDKit from SMILES.

Molecular weight 452.50 Da
LogP (Crippen) 4.47
H-bond donors 0
H-bond acceptors 3
TPSA 57.69 Ų
Rotatable bonds 3
Aromatic rings 2 / 4
Heavy atoms 31
Fraction sp³ C 0.41
Formula C₂₂H₂₃F₃N₂O₃S

Drug-likeness

Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.

Permeability proxy High

Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.

  • TPSA ≤ 90 Ų 57.7
  • −1 ≤ LogP ≤ 5 4.47
Lipinski's Rule of Five Pass 0 violations
  • MW ≤ 500 Da 452.5
  • LogP ≤ 5 4.47
  • H-bond donors ≤ 5 0
  • H-bond acceptors ≤ 10 3
Veber's rules Pass
  • Rotatable bonds ≤ 10 3
  • TPSA ≤ 140 Ų 57.7
PAINS Clean

No PAINS structural alerts detected.

Chemical representations

Canonical representations for cheminformatics workflows.

SMILES
O=C(c1cccc(C(F)(F)F)c1)N1CCCc2cc(S(=O)(=O)N3CCCCC3)ccc21
InChI
InChI=1S/C22H23F3N2O3S/c23-22(24,25)18-8-4-6-17(14-18)21(28)27-13-5-7-16-15-19(9-10-20(16)27)31(29,30)26-11-2-1-3-12-26/h4,6,8-10,14-15H,1-3,5,7,11-13H2
InChIKey
CIUFXBUVLIXIAS-UHFFFAOYSA-N

Provenance

Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.

Method
LigQ sequence
Query
OKV
Homolog
A6T5R0

External resources

Open this ligand in third-party databases and cheminformatics tools.

Other ligands for this protein

Quick navigation to other ligands bound to KP13_03591.

PDB 2

Ligands co-crystallized with this protein (structural evidence).

Ligand PDB entry

ZINC 49

Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).

Compound Similarity (Tanimoto)